Literature DB >> 25083536

Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.

Vikas Kapil, Jody L Green, Marie-Claire Le Lait, David M Wood, Paul I Dargan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25083536      PMCID： PMC4168395          DOI： 10.1111/bcp.12277

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Pregabalin in clinical psychiatry and addiction: pros and cons.

Authors:  Giovanni Martinotti
Journal:  Expert Opin Investig Drugs       Date:  2012-06-24       Impact factor: 6.206

2.  Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data.

Authors:  Fabrizio Schifano; Stefano D'Offizi; Michele Piccione; Ornella Corazza; Paolo Deluca; Zoe Davey; Giuditta Di Melchiorre; Lucia Di Furia; Magí Farré; Liv Flesland; Miia Mannonen; Aino Majava; Stefania Pagani; Teuvo Peltoniemi; Holger Siemann; Arvid Skutle; Marta Torrens; Cinzia Pezzolesi; Peer van der Kreeft; Norbert Scherbaum
Journal:  Psychother Psychosom       Date:  2011-01-04       Impact factor: 17.659

Review 3.  Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).

Authors:  David M Wood; Alan D Brailsford; Paul I Dargan
Journal:  Drug Test Anal       Date:  2011-05-06       Impact factor: 3.345

4.  Baclofen and gamma-hydroxybutyrate withdrawal.

Authors:  Jennifer L LeTourneau; Daniel S Hagg; Stephen M Smith
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210
  4 in total
  23 in total

Review 1.  Abuse Potential of Pregabalin: A Systematic Review.

Authors:  Ole Schjerning; Mary Rosenzweig; Anton Pottegård; Per Damkier; Jimmi Nielsen
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

Review 2.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 3.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

4.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

5.  Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors:  Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

6.  Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.

Authors:  Mance E Buttram; Steven P Kurtz
Journal:  J Psychoactive Drugs       Date:  2020-02-27

7.  Pregabalin Use Among Users of Illicit Drugs: A Cross-Sectional Survey in Southern Germany.

Authors:  Brendan J Snellgrove; Tilman Steinert; Susanne Jaeger
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

8.  A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky.

Authors:  Rachel Vickers Smith; Elaine M Boland; April M Young; Michelle R Lofwall; Alexa Quiroz; Michele Staton; Jennifer R Havens
Journal:  Psychol Addict Behav       Date:  2017-12-14

9.  Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database.

Authors:  Jean-Baptiste Bossard; Camille Ponté; Julie Dupouy; Maryse Lapeyre-Mestre; Emilie Jouanjus
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

10.  Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.

Authors:  Rachel Vickers-Smith; Jiangwen Sun; Richard J Charnigo; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens
Journal:  Drug Alcohol Depend       Date:  2019-11-02       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.